Beverwijk, Netherlands

Wilhelmina M C Van Roon-Mom

This inventor holds 3 USPTO granted patents. Top assignees: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Academisch Ziekenhuis Leiden. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wilhelmina M C Van Roon-Mom. Retrieved from https://idiyas.com/inventor/wilhelmina-m-c-van-roon-mom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wilhelmina M C Van Roon-Mom: Innovator in Antisense Oligonucleotide Technology

Introduction

Wilhelmina M C Van Roon-Mom is a notable inventor based in Beverwijk, Netherlands. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotide technologies. With a total of 3 patents, his work focuses on innovative methods for protein modification and gene therapy.

Latest Patents

His latest patents include groundbreaking inventions such as "Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansions." This patent describes methods for removing a proteolytic cleavage site, the HCHWA-D mutation, or the amino acids encoded by a trinucleotide repeat expansion from a protein. The process involves providing a cell that expresses pre-mRNA encoding the protein with an antisense oligonucleotide that induces skipping of the exonic sequence that comprises the targeted elements. The method further includes allowing translation of mRNA produced from the pre-mRNA. Another significant patent is "Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins." This invention relates to means and methods for removing a proteolytic cleavage site from a protein, utilizing a similar approach of inducing skipping of the exonic sequence.

Career Highlights

Throughout his career, Wilhelmina has worked with prestigious institutions, including Academisch Ziekenhuis Leiden and its associated entity, Lumc. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

He has collaborated with notable colleagues such as Melvin Maurice Evers and Barry Antonius Pepers. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Wilhelmina M C Van Roon-Mom's contributions to antisense oligonucleotide technology exemplify the impact of innovative thinking in molecular biology. His patents reflect a commitment to advancing scientific knowledge and improving therapeutic techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…